El-Saie A, Varghese NP, Webb MK, Villafranco N, Gandhi B, Guaman MC, et al. Bronchopulmonary dysplasia - associated pulmonary hypertension: an updated review. Semin Perinatol. 2023;47:151817.
Article PubMed PubMed Central Google Scholar
Cuevas Guaman M, Dahm PH, Welty SE. The challenge of accurately describing the epidemiology of bronchopulmonary dysplasia (bpd) based on the various current definitions of bpd. Pediatr Pulmonol. 2021;56:3527–32.
Hansmann G, Sallmon H, Roehr CC, Kourembanas S, Austin ED, Koestenberger M, et al. Pulmonary hypertension in bronchopulmonary dysplasia. Pediatr Res. 2021;89:446–55.
Khemani E, McElhinney DB, Rhein L, Andrade O, Lacro RV, Thomas KC, et al. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics. 2007;120:1260–9.
Ong MS, Abman S, Austin ED, Feinstein JA, Hopper RK, Krishnan US, et al. Racial and ethnic differences in pediatric pulmonary hypertension: an analysis of the pediatric pulmonary hypertension network registry. J Pediatr. 2019;211:63–71.e66.
Article PubMed PubMed Central Google Scholar
Arjaans S, Haarman MG, Roofthooft MTR, Fries MWF, Kooi EMW, Bos AF, et al. Fate of pulmonary hypertension associated with bronchopulmonary dysplasia beyond 36 weeks postmenstrual age. Arch Dis Child Fetal Neonatal Ed. 2021;106:45–50.
Greenberg RG, McDonald SA, Laughon MM, Tanaka D, Jensen E, Van Meurs K, et al. Online clinical tool to estimate risk of bronchopulmonary dysplasia in extremely preterm infants. Arch Dis Childhood-Fetal and Neonatal Ed. 2022;107:638–43.
Laughon MM, Langer JC, Bose CL, Smith PB, Ambalavanan N, Kennedy KA, et al. Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants. Am J Respir Crit Care Med. 2011;183:1715–22.
Article PubMed PubMed Central Google Scholar
Nagiub M, Kanaan U, Simon D, Guglani L. Risk factors for development of pulmonary hypertension in infants with bronchopulmonary dysplasia: Systematic review and meta-analysis. Paediatr Respir Rev. 2017;23:27–32.
Sheth S, Goto L, Bhandari V, Abraham B, Mowes A. Factors associated with development of early and late pulmonary hypertension in preterm infants with bronchopulmonary dysplasia. J Perinatol. 2020;40:138–48.
Article PubMed CAS Google Scholar
Beam K, Sharma P, Levy P, Beam AL. Artificial intelligence in the neonatal intensive care unit: the time is now. J Perinatol. 2024;44:131–5.
Jensen EA, Dysart K, Gantz MG, McDonald S, Bamat NA, Keszler M, et al. The diagnosis of bronchopulmonary dysplasia in very preterm infants. An evidence-based approach. Am J Respir Crit Care Med. 2019;200:751–9.
Article PubMed PubMed Central CAS Google Scholar
Spitzer AR, Ellsbury DL, Handler D, Clark RH. The pediatrix babysteps data warehouse and the pediatrix qualitysteps improvement project system-tools for “meaningful use” in continuous quality improvement. Clin Perinatol. 2010;37:49–70.
Schneider S, Bailey M, Spears T, Esther CR Jr., Laughon MM, Hornik CP, et al. Safety of sildenafil in premature infants with severe bronchopulmonary dysplasia (sildi-safe): a multicenter, randomized, placebo-controlled, sequential dose-escalating, double-masked, safety study. BMC Pediatr. 2020;20:559.
Article PubMed PubMed Central Google Scholar
Hochreiter S. Long short-term memory. Neural Comput. 1997;9:1735–80.
Little RJ, Rubin DB. Statistical analysis with missing data. John Wiley & Sons; 2019.
Ghorbani A, Zou JY. Embedding for informative missingness: Deep learning with incomplete data. In: 56th annual allerton conference on communication, control, and computing (Allerton). IEEE; 2018. 437–45.
Li L, Jamieson K, DeSalvo G, Rostamizadeh A, Talwalkar A. Hyperband: A novel bandit-based approach to hyperparameter optimization. J Mach Learn Res. 2018;18:1–52.
Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33:1.
Article PubMed PubMed Central Google Scholar
Wong HR, Atkinson SJ, Cvijanovich NZ, Anas N, Allen GL, Thomas NJ, et al. Combining prognostic and predictive enrichment strategies to identify children with septic shock responsive to corticosteroids. Crit Care Med. 2016;44:e1000–3.
Article PubMed PubMed Central CAS Google Scholar
Engelhard MM, Navar AM, Pencina MJ. Incremental benefits of machine learning-when do we need a better mousetrap?. JAMA Cardiol. 2021;6:621–3.
Sanchez-Pinto LN, Bennett TD. Evaluation of machine learning models for clinical prediction problems. Pediatr Crit Care Med. 2022;23:405–8.
Article PubMed PubMed Central Google Scholar
Charles E, Hunt KA, Harris C, Hickey A, Greenough A. Small for gestational age and extremely low birth weight infant outcomes. J Perinat Med. 2019;47:247–51.
Article PubMed CAS Google Scholar
Pierro M, Villamor-Martinez E, van Westering-Kroon E, Alvarez-Fuente M, Abman SH, Villamor E. Association of the dysfunctional placentation endotype of prematurity with bronchopulmonary dysplasia: a systematic review, meta-analysis and meta-regression. Thorax. 2022;77:268–75.
Hansmann G, Koestenberger M, Alastalo TP, Apitz C, Austin ED, Bonnet D, et al. 2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPCC, ESPR and ISHLT. J Heart Lung Transplant. 2019;38:879–901.
Greenberg RG, Gayam S, Savage D, Tong A, Gorham D, Sholomon A, et al. Furosemide exposure and prevention of bronchopulmonary dysplasia in premature infants. J Pediatr. 2019;208:134–40.e132.
Article PubMed CAS Google Scholar
Choi EK, Jung YH, Kim HS, Shin SH, Choi CW, Kim EK, et al. The impact of atrial left-to-right shunt on pulmonary hypertension in preterm infants with moderate or severe bronchopulmonary dysplasia. Pediatr Neonatol. 2015;56:317–23.
Vyas-Read S, Guglani L, Shankar P, Travers C, Kanaan U. Atrial septal defects accelerate pulmonary hypertension diagnoses in premature infants. Front Pediatr. 2018;6:342.
Article PubMed PubMed Central Google Scholar
Doyle LW, Cheong JL, Hay S, Manley BJ, Halliday HL. Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst Rev. 2021;10:CD001146.
PubMed PubMed Central Google Scholar
van de Loo M, van Kaam A, Offringa M, Doyle LW, Cooper C, Onland W. Corticosteroids for the prevention and treatment of bronchopulmonary dysplasia: an overview of systematic reviews. Cochrane Database Syst Rev. 2024;4:Cd013271.
PubMed PubMed Central Google Scholar
Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, et al. Caffeine therapy for apnea of prematurity. N Engl J Med. 2006;354:2112–21.
Article PubMed CAS Google Scholar
Ploegstra MJ, Zijlstra WMH, Douwes JM, Hillege HL, Berger RMF. Prognostic factors in pediatric pulmonary arterial hypertension: a systematic review and meta-analysis. Int J Cardiol. 2015;184:198–207.
McCrary AW, Barker PCA, Torok RD, Spears TG, Li JS, Hornik CP, et al. Agreement of an echocardiogram-based diagnosis of pulmonary hypertension in infants at risk for bronchopulmonary dysplasia among masked reviewers. J Perinatol. 2019;39:248–55.
Burkett DA, Patel SS, Mertens L, Friedberg MK, Ivy DD. Relationship between left ventricular geometry and invasive hemodynamics in pediatric pulmonary hypertension. Circ Cardiovasc Imaging. 2020;13:e009825.
Article PubMed PubMed Central Google Scholar
Krishnan U, Feinstein JA, Adatia I, Austin ED, Mullen MP, Hopper RK, et al. Evaluation and management of pulmonary hypertension in children with bronchopulmonary dysplasia. J Pediatr. 2017;188:24–34.e21.
Comments (0)